More RSV vaccines may be on the way, too. Moderna is finishing its Phase 3 trial of an mRNA vaccine for RSV in older adults and expects to submit results to the FDA within the next few months.

The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.

Multiple healthcare organizations that have historically helped the CDC's Advisory Committee on Immunization Practices (ACIP) ...

A CDC advisory committee recommended approval of an RSV vaccine for adults aged 60 and older. What this means for a potential fall rollout.

Prior to this, the CDC recommended that everyone over the age of 60 have the option of receiving an RSV vaccine dose. “This recommendation is for adults who did not get an RSV vaccine last year.

Earlier this year, a group of vaccine experts on the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to expand RSV vaccination to high-risk adults starting at age 50.

The world’s first approved vaccines to combat respiratory syncytial virus should be recommended for all Americans 65 and over, a federal advisory panel decided Wednesday. The Advisory Committee ...

In June, the CDC gave its approval to both Abrysvo and GSK's Arexvy vaccine as protections against RSV for adults ages 60 and older. The previous month, Arexvy became the first RSV vaccine to ever ...

Pregnant people should get an RSV vaccine from Pfizer that transfers antibodies to their babies, according to a new CDC recommendation. It's the first RSV shot of its kind.

The CDC has recommended that expectant mothers get an RSV vaccine if they are between 32 and 36 weeks pregnant and will give birth during the fall and winter. (LM Otero/AP) ...

The CDC's Advisory Committee on Immunization Practices on Thursday weighed recommendations for two RSV vaccines for older adults and pregnant people, and a monoclonal antibody for babies and toddlers.